Longhui Medical is a 2017-founded medical robotics R&D company that is making significant strides in advancing the future of joint replacement surgery. The company's slogan, "Advancing the future of joint replacement surgery with innovative robotics, from concept to care," encapsulates its commitment to innovation and patient care. Specializing in joint replacement surgery robots, product development, sales, and service, Longhui Medical operates within the Health Care and Robotics industries. The company received a notable CNY100.00M Series B investment on 26 November 2021 from Sinopharm Capital, Sunland Capital, and FTZ Fund. This latest investment signifies an important milestone for Longhui Medical as it continues to make strides in the medical robotics industry. With its innovative approach and support from key investors, Longhui Medical is poised to be a significant player in the future of joint replacement surgery.
No recent news or press coverage available for Longhui Medical.